Injection/Infusion
CYTARABINE KABI SOLUTION FOR INJECTION OR INFUSION 100MG/1ML
Summary
CYTARABINE KABI SOLUTION FOR INJECTION OR INFUSION 100MG/1ML — Injection/Infusion containing cytarabine. Hong Kong Registration No. HK-66210. Certificate Holder: FRESENIUS KABI HONG KONG LIMITED. Date of Registration: 29 Apr, 2019.
Product NameCYTARABINE KABI SOLUTION FOR INJECTION OR INFUSION 100MG/1ML
Registration No.HK-66210
Certificate HolderFRESENIUS KABI HONG KONG LIMITED
Holder AddressROOM 5001-16, 50/F, SUN HUNG KAI CENTRE, 30, HARBOUR ROAD, WAN CHAI, HONG KONG
Ingredientscytarabine
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration29 Apr, 2019
ATC codesL01BC01
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL01
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。